Search - tctmd.com

Displaying 981 - 1000 of 1233

Sort: Relevancy | Date

Presentation

Gender Differences in LV Function Following PCI for First Anterior Wall STEMI

Presenter: Adaya Weissler-Snir

September 11, 2014

Presentation

STEMI Patients Randomized to a Pharmacoinvasive Strategy or Primary PCI

Presenter: P. R. Sinnaeve

September 09, 2014

Presentation

Post-Procedural Anticoagulation for Specific Indications After Revascularization for STEMI

Presenter: M. V. Madhavan

August 27, 2014

Presentation

Randomized Comparison of EES and SES in Patients With STEMI

Presenter: E. Di Lorenzo

August 22, 2014

Presentation

Impact of Time of Presentation on Process Performance and Outcomes in STEMI

Presenter: T. W. Dasari

July 30, 2014

Presentation BRS 2014

Results of BVS in NSTEMI and STEMI POLAR ACS, PRAGUE 19, BVS STEMI FIRSTand a View to TROFI-II

Presenter: Roberto Diletti

July 26, 2014

Presentation

REWARD-MI: Real-World Comparison of the MGuard Stent vs BMS for STEMI

Presenter: Agust?n Fern?ndez-Cisnal

July 02, 2014

Presentation

Stent Thrombosis in New-Generation DES in Patients with STEMI Undergoing Primary PCI in SCAAR

Presenter: Giovanna Sarno

July 01, 2014

Presentation

STEMI in China from 2001-2011 (The China PEACE-Retrospective Acute Myocardial Infarction Study)

Presenter: Lixin Jiang

June 24, 2014

Presentation

Aborted MI in STEMI

Presenter: N.D. Maleki

June 23, 2014

Presentation

Influence of Coronary Vessel Dominance on Short- and Long-term Outcome in Patients After STEMI

Presenter: C.E. Veltman

June 19, 2014

Presentation

Prasugrel vs Clopidogrel in STEMI Patients According to Timing of PCI

Presenter: J.A. Udell

June 17, 2014

Presentation

Optimization in Stent Implantation by Manual Thrombus Aspiration in STEMI

Presenter: D. Fern?ndez-Rodriguez

June 03, 2014

$Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial$

Presentation EuroPCR 2014

Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial

Presenter: Uwe Zeymer

May 21, 2014

Presentation

Prasugrel plus Bivalirudin vs Clopidogrel plus Heparin in Patients with STEMI

Presenter: Stefanie Schulz

May 14, 2014

Presentation

Early Eplerenone Treatment in Patients with Acute STEMI Without HF: The REMINDER Study

Presenter: 140896|Gilles Montalescot

May 05, 2014

Presentation

Frequency of Non-system Delays in STEMI Patients Undergoing Primary PCI and Implications for D2B Time Reporting

Presenter: D.A. Cotoni

April 28, 2014

Presentation

Delay in Reperfusion with Transradial PCI for STEMI: Might Some Delays Be Acceptable?

Presenter: N.J. Wimmer

April 18, 2014

Presentation

Prevention of CIN with N-acetylcysteine or Sodium Bicarbonate in Patients with STEMI

Presenter: Per Thayssen

April 15, 2014

Presentation Fellows 2014

State-of-the-Art in ACS and STEMI: Risk Stratification, Reperfusion Strategies, and Guidelines

Presenter: Gregg Stone

April 12, 2014

Advertisement

Gender Differences in LV Function Following PCI for First Anterior Wall STEMI

STEMI Patients Randomized to a Pharmacoinvasive Strategy or Primary PCI

Post-Procedural Anticoagulation for Specific Indications After Revascularization for STEMI

Randomized Comparison of EES and SES in Patients With STEMI

Impact of Time of Presentation on Process Performance and Outcomes in STEMI

Results of BVS in NSTEMI and STEMI POLAR ACS, PRAGUE 19, BVS STEMI FIRSTand a View to TROFI-II

REWARD-MI: Real-World Comparison of the MGuard Stent vs BMS for STEMI

Stent Thrombosis in New-Generation DES in Patients with STEMI Undergoing Primary PCI in SCAAR

STEMI in China from 2001-2011 (The China PEACE-Retrospective Acute Myocardial Infarction Study)

Aborted MI in STEMI

Influence of Coronary Vessel Dominance on Short- and Long-term Outcome in Patients After STEMI

Prasugrel vs Clopidogrel in STEMI Patients According to Timing of PCI

Optimization in Stent Implantation by Manual Thrombus Aspiration in STEMI

Routine bivalirudin is superior to unfractionated heparin + bailout GP IIb/IIIa inhibitors in patients with STEMI transported for primary PCI: A prespecified subgroup analysis of the EUROMAX trial

Prasugrel plus Bivalirudin vs Clopidogrel plus Heparin in Patients with STEMI

Early Eplerenone Treatment in Patients with Acute STEMI Without HF: The REMINDER Study

Frequency of Non-system Delays in STEMI Patients Undergoing Primary PCI and Implications for D2B Time Reporting

Delay in Reperfusion with Transradial PCI for STEMI: Might Some Delays Be Acceptable?

Prevention of CIN with N-acetylcysteine or Sodium Bicarbonate in Patients with STEMI

State-of-the-Art in ACS and STEMI: Risk Stratification, Reperfusion Strategies, and Guidelines

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content